story of the week
Ibrutinib–Rituximab or Chemoimmunotherapy for CLL
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Ibrutinib-Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia
N. Engl. J. Med 2019 Aug 01;381(5)432-443, TD Shanafelt, XV Wang, NE Kay, CA Hanson, S O'Brien, J Barrientos, DF Jelinek, E Braggio, JF Leis, CC Zhang, SE Coutre, PM Barr, AF Cashen, AR Mato, AK Singh, MP Mullane, RF Little, H Erba, RM Stone, M Litzow, M TallmanFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.